Sultriecin (CAS 131774-59-9)

Sultriecin is a sulfur-containing antibiotic derived from the bacterium Streptomyces tendae. Its unique chemical structure features a thiotetronate motif, which is essential for its biological activity, primarily targeting bacterial protein synthesis. Sultriecin acts by binding to the 50S ribosomal subunit of bacteria, thereby inhibiting the peptidyl transferase center. This binding disrupts the elongation phase of protein synthesis, effectively preventing the formation of peptide bonds between amino acids, which is crucial for protein production. In research, sultriecin has been utilized to study bacterial resistance mechanisms and the dynamics of protein synthesis. Its ability to inhibit ribosomal function makes it a valuable tool for investigating the intricacies of ribosomal structures and functions, as well as examining how antibiotics can modulate these processes. Moreover, studies involving sultriecin have contributed to a deeper understanding of the molecular basis of antibiotic action, particularly how thiotetronate compounds interact with ribosomal components to exert their effects. This research is vital for developing new strategies to combat antibiotic resistance, providing insights that could lead to the synthesis of novel antibiotics with improved efficacy against resistant bacterial strains.